Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Company Overview
Henry Schein, Inc. is a global provider of healthcare solutions primarily serving dental and medical professionals. The company operates in the healthcare distribution and services industry, supplying consumable products, equipment, technology, and value-added services that support clinical care and practice management. Its core customers include dentists, dental laboratories, physicians, medical offices, and alternate care sites, with a strong emphasis on small- and mid-sized practices.
The company generates revenue mainly through the distribution of branded and private-label consumables, dental and medical equipment, and practice management software, complemented by financial, logistics, and advisory services. Henry Schein is positioned as a full-solution partner rather than a pure distributor, leveraging scale, data, and technology to integrate supply chain efficiency with practice support. Founded in 1932 as a mail-order pharmacy, the company expanded into dental distribution in the 1970s and medical distribution in the 1990s, evolving through acquisitions and organic growth into a diversified global healthcare solutions provider.
Business Operations
Henry Schein operates through two primary reportable segments: Global Dental and Global Medical. The Global Dental segment represents the majority of revenue and includes the distribution of dental consumables, equipment, and technology, as well as laboratory products and digital dentistry solutions. The Global Medical segment focuses on medical supplies, vaccines, and equipment for physician offices, ambulatory surgery centers, and other alternate care settings. Revenue is generated through product sales, equipment installations, software licensing, and recurring service and support arrangements.
Operations span both domestic and international markets, with integrated logistics networks, distribution centers, and digital ordering platforms. The company controls proprietary technologies such as Dentrix, Dentrix Ascend, and Henry Schein One practice management systems, and maintains long-standing supplier relationships with major healthcare manufacturers. Key subsidiaries include Henry Schein One (a dental software joint venture) and BioHorizons and Camlog (dental implant businesses), which extend the company’s presence into higher-margin specialty categories.
Strategic Position & Investments
Henry Schein’s strategy centers on deepening customer relationships through technology-enabled solutions, expanding specialty offerings, and driving operational efficiency. Growth initiatives include investment in digital dentistry, data-driven practice management tools, and specialty dental markets such as implants and orthodontics. The company has also emphasized supply chain optimization and private-label product expansion to enhance margins.
Notable investments and acquisitions include full ownership of BioHorizons and Camlog, which together form a global dental implant platform, and the continued development of Henry Schein One, which consolidates dental software assets to support cloud-based and analytics-driven practice solutions. The company has selectively exited or restructured non-core or lower-margin operations, signaling a focus on disciplined capital allocation and return on invested capital rather than broad-based expansion.
Geographic Footprint
Henry Schein is headquartered in North America (Melville, New York) and operates in more than 30 countries. Its largest market is the United States, which accounts for the majority of revenue, followed by significant operations across Europe, including Germany, the United Kingdom, France, Italy, and Spain. The company also maintains a presence in Asia-Pacific and Latin America, primarily through dental distribution and specialty product businesses.
International operations are supported by regional distribution centers, localized sales forces, and country-specific regulatory expertise. While the company does not operate manufacturing at scale, its global sourcing, logistics, and software platforms provide international reach and operational influence across multiple healthcare systems.
Leadership & Governance
Henry Schein is led by a management team with long tenure in healthcare distribution and services, emphasizing customer-centric solutions, decentralized operations, and disciplined financial management. The leadership philosophy prioritizes long-term value creation, strong supplier and customer partnerships, and responsible corporate governance.
Key executives include:
- Stanley M. Bergman – Chairman of the Board and Chief Executive Officer
- Ronald P. South – Chief Financial Officer
- Timothy A. McDevitt – Chief Operating Officer
- Andrea Albertini – Chief Administrative Officer
- Jennifer Kim – Chief Strategy Officer
The board of directors includes independent members with backgrounds in healthcare, finance, and global operations, and governance practices align with U.S. public company standards as outlined in SEC filings and corporate governance disclosures.